Lack of correlation between outcomes of membrane repair assay and correction of dystrophic changes in experimental therapeutic strategy in dysferlinopathy.
Mutations in the dysferlin gene are the cause of Limb-girdle Muscular Dystrophy type 2B and Miyoshi Myopathy. The dysferlin protein has been implicated in sarcolemmal resealing, leading to the idea that the pathophysiology of dysferlin deficiencies is due to a deficit in membrane repair. Here, we sh...
Guardado en:
Autores principales: | William Lostal, Marc Bartoli, Carinne Roudaut, Nathalie Bourg, Martin Krahn, Marina Pryadkina, Perrine Borel, Laurence Suel, Joseph A Roche, Daniel Stockholm, Robert J Bloch, Nicolas Levy, Rumaisa Bashir, Isabelle Richard |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ab23a3d6ce924c7caaba2d978af7e9af |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Phenotypic Drug Screening for Dysferlinopathy Using Patient‐Derived Induced Pluripotent Stem Cells
por: Yuko Kokubu, et al.
Publicado: (2019) -
Decrease in prosaposin in the Dystrophic mdx mouse brain.
por: Hui-Ling Gao, et al.
Publicado: (2013) -
The Qualitative Effects of Resveratrol and Coenzyme Q10 Administration on the Gluteus Complex Muscle Morphology of SJL/J Mice with Dysferlinopathy
por: van der Spuy,Wendy Jeannette, et al.
Publicado: (2011) -
Novel insight into stem cell trafficking in dystrophic muscles
por: Farini A, et al.
Publicado: (2012) -
Defective dystrophic thymus determines degenerative changes in skeletal muscle
por: Andrea Farini, et al.
Publicado: (2021)